Organigram Global (OGI) Competitors

$1.10 -0.02 (-1.79%)

As of 02:53 PM Eastern

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

Should you buy Organigram Global stock or one of its competitors? MarketBeat compares Organigram Global with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Organigram Global include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), SNDL (SNDL), and Tilray Brands (TLRY). These companies are all part of the "pharmaceutical products" industry.

How does Organigram Global compare to Aurora Cannabis?

Organigram Global (NASDAQ:OGI) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability, media sentiment and institutional ownership.

Organigram Global has a beta of 1.5, meaning that its share price is 50% more volatile than the broader market. Comparatively, Aurora Cannabis has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

34.6% of Organigram Global shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 0.1% of Organigram Global shares are owned by company insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Organigram Global has a net margin of -9.22% compared to Aurora Cannabis' net margin of -23.46%. Aurora Cannabis' return on equity of -0.04% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.49%	-8.99%
Aurora Cannabis	-23.46%	-0.04%	-0.03%

Aurora Cannabis has higher revenue and earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$279.99M	0.56	-$17.70M	-$0.13	N/A
Aurora Cannabis	$373.12M	0.53	$1.63M	-$1.08	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Aurora Cannabis	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Organigram Global had 8 more articles in the media than Aurora Cannabis. MarketBeat recorded 12 mentions for Organigram Global and 4 mentions for Aurora Cannabis. Aurora Cannabis' average media sentiment score of 0.96 beat Organigram Global's score of 0.18 indicating that Aurora Cannabis is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Aurora Cannabis	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Organigram Global beats Aurora Cannabis on 8 of the 15 factors compared between the two stocks.

How does Organigram Global compare to Canopy Growth?

Canopy Growth (NASDAQ:CGC) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Organigram Global has a net margin of -9.22% compared to Canopy Growth's net margin of -94.39%. Organigram Global's return on equity of -13.49% beat Canopy Growth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Canopy Growth	-94.39%	-46.85%	-28.95%
Organigram Global	-9.22%	-13.49%	-8.99%

Organigram Global has higher revenue and earnings than Canopy Growth. Organigram Global is trading at a lower price-to-earnings ratio than Canopy Growth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Canopy Growth	$225.65M	1.93	-$429.86M	-$1.30	N/A
Organigram Global	$279.99M	0.56	-$17.70M	-$0.13	N/A

Canopy Growth has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

In the previous week, Organigram Global had 5 more articles in the media than Canopy Growth. MarketBeat recorded 12 mentions for Organigram Global and 7 mentions for Canopy Growth. Canopy Growth's average media sentiment score of 0.95 beat Organigram Global's score of 0.18 indicating that Canopy Growth is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Canopy Growth	2 Very Positive mention(s)	3 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

3.3% of Canopy Growth shares are held by institutional investors. Comparatively, 34.6% of Organigram Global shares are held by institutional investors. 0.2% of Canopy Growth shares are held by insiders. Comparatively, 0.1% of Organigram Global shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Canopy Growth	2 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Organigram Global beats Canopy Growth on 10 of the 14 factors compared between the two stocks.

How does Organigram Global compare to Cronos Group?

Organigram Global (NASDAQ:OGI) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, valuation, analyst recommendations, media sentiment, dividends, risk, institutional ownership and earnings.

Organigram Global has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market. Comparatively, Cronos Group has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market.

Cronos Group has a net margin of -1.14% compared to Organigram Global's net margin of -9.22%. Cronos Group's return on equity of -1.26% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Organigram Global	-9.22%	-13.49%	-8.99%
Cronos Group	-1.14%	-1.26%	-1.20%

In the previous week, Cronos Group had 1 more articles in the media than Organigram Global. MarketBeat recorded 13 mentions for Cronos Group and 12 mentions for Organigram Global. Cronos Group's average media sentiment score of 0.86 beat Organigram Global's score of 0.18 indicating that Cronos Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cronos Group	5 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

34.6% of Organigram Global shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.1% of Organigram Global shares are held by insiders. Comparatively, 7.8% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Cronos Group has lower revenue, but higher earnings than Organigram Global. Organigram Global is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Organigram Global	$279.99M	0.56	-$17.70M	-$0.13	N/A
Cronos Group	$159.54M	6.45	-$9.45M	$0.01	273.50

Cronos Group has a consensus price target of $2.30, indicating a potential downside of 15.90%. Given Cronos Group's higher probable upside, analysts clearly believe Cronos Group is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Cronos Group	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

Summary

Cronos Group beats Organigram Global on 11 of the 15 factors compared between the two stocks.

How does Organigram Global compare to SNDL?

SNDL (NASDAQ:SNDL) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and media sentiment.

SNDL has higher revenue and earnings than Organigram Global. SNDL is trading at a lower price-to-earnings ratio than Organigram Global, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SNDL	$677.32M	0.55	-$11.29M	-$0.03	N/A
Organigram Global	$279.99M	0.56	-$17.70M	-$0.13	N/A

In the previous week, Organigram Global had 11 more articles in the media than SNDL. MarketBeat recorded 12 mentions for Organigram Global and 1 mentions for SNDL. SNDL's average media sentiment score of 1.89 beat Organigram Global's score of 0.18 indicating that SNDL is being referred to more favorably in the media.

Company	Overall Sentiment
SNDL	Very Positive
Organigram Global	Neutral

SNDL has a net margin of -1.19% compared to Organigram Global's net margin of -9.22%. SNDL's return on equity of -1.02% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SNDL	-1.19%	-1.02%	-0.85%
Organigram Global	-9.22%	-13.49%	-8.99%

34.6% of Organigram Global shares are held by institutional investors. 0.1% of Organigram Global shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

SNDL has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, meaning that its stock price is 50% more volatile than the broader market.

SNDL currently has a consensus price target of $5.00, suggesting a potential upside of 245.07%. Given SNDL's higher possible upside, research analysts plainly believe SNDL is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SNDL	2 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.67
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

SNDL and Organigram Global tied by winning 8 of the 16 factors compared between the two stocks.

How does Organigram Global compare to Tilray Brands?

Tilray Brands (NASDAQ:TLRY) and Organigram Global (NASDAQ:OGI) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, media sentiment, earnings, profitability, analyst recommendations, valuation and risk.

In the previous week, Tilray Brands had 4 more articles in the media than Organigram Global. MarketBeat recorded 16 mentions for Tilray Brands and 12 mentions for Organigram Global. Tilray Brands' average media sentiment score of 0.81 beat Organigram Global's score of 0.18 indicating that Tilray Brands is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tilray Brands	8 Very Positive mention(s)	4 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Organigram Global	0 Very Positive mention(s)	2 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

9.4% of Tilray Brands shares are owned by institutional investors. Comparatively, 34.6% of Organigram Global shares are owned by institutional investors. 0.8% of Tilray Brands shares are owned by insiders. Comparatively, 0.1% of Organigram Global shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Tilray Brands currently has a consensus price target of $11.50, suggesting a potential upside of 109.24%. Given Tilray Brands' higher possible upside, equities research analysts clearly believe Tilray Brands is more favorable than Organigram Global.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tilray Brands	1 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.25
Organigram Global	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Organigram Global has a net margin of -9.22% compared to Tilray Brands' net margin of -156.51%. Tilray Brands' return on equity of -3.31% beat Organigram Global's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tilray Brands	-156.51%	-3.31%	-2.42%
Organigram Global	-9.22%	-13.49%	-8.99%

Tilray Brands has a beta of 1.94, suggesting that its stock price is 94% more volatile than the broader market. Comparatively, Organigram Global has a beta of 1.5, suggesting that its stock price is 50% more volatile than the broader market.

Organigram Global has higher revenue and earnings than Tilray Brands. Organigram Global is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tilray Brands	$210.48M	3.04	-$2.19B	-$13.65	N/A
Organigram Global	$279.99M	0.56	-$17.70M	-$0.13	N/A

Summary

Tilray Brands beats Organigram Global on 10 of the 16 factors compared between the two stocks.

Get Organigram Global News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OGI vs. The Competition

Export

Metric	Organigram Global	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$155.55M	$7.98B	$6.29B	$12.48B
Dividend Yield	N/A	2.50%	2.79%	5.30%
P/E Ratio	-8.50	18.42	20.91	25.60
Price / Sales	0.56	7.71	548.78	75.41
Price / Cash	N/A	16.76	42.94	55.34
Price / Book	0.59	3.67	9.87	6.72
Net Income	-$17.70M	$223.05M	$3.55B	$333.73M
7 Day Performance	-19.93%	-2.02%	-0.24%	0.38%
1 Month Performance	-22.73%	3.03%	1.44%	4.02%
1 Year Performance	-9.43%	1.98%	41.01%	36.37%

Organigram Global Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OGI Organigram Global	1.0333 of 5 stars	$1.11 -0.9%	N/A	-10.1%	$155.55M	$279.99M	N/A	1,139	News Coverage Earnings Report
ACB Aurora Cannabis	1.1142 of 5 stars	$3.44 +0.6%	N/A	-35.3%	$203.33M	$373.12M	N/A	1,130
CGC Canopy Growth	2.1121 of 5 stars	$1.08 -1.8%	N/A	-24.8%	$436.45M	$278.39M	N/A	3,150
CRON Cronos Group	1.6821 of 5 stars	$2.63 -0.8%	$2.30 -12.5%	+33.8%	$989.59M	$146.59M	N/A	450	Earnings Report Analyst Forecast
SNDL SNDL	3.7479 of 5 stars	$1.43 +0.7%	$5.00 +249.7%	+6.8%	$368.08M	$677.32M	N/A	2,751	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OGI) was last updated on 5/14/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Summary

How does Organigram Global compare to Canopy Growth?

Summary

How does Organigram Global compare to Cronos Group?

Summary

How does Organigram Global compare to SNDL?

Summary

How does Organigram Global compare to Tilray Brands?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Organigram Global (OGI) Competitors

OGI vs. ACB, CGC, CRON, SNDL, and TLRY

How does Organigram Global compare to Aurora Cannabis?

Which has more risk and volatility, OGI or ACB?

Do insiders and institutionals hold more shares of OGI or ACB?

Is OGI or ACB more profitable?

Which has stronger valuation and earnings, OGI or ACB?

Do analysts recommend OGI or ACB?

Does the media prefer OGI or ACB?

Summary

How does Organigram Global compare to Canopy Growth?

Is CGC or OGI more profitable?

Which has preferable earnings & valuation, CGC or OGI?

Which has more risk and volatility, CGC or OGI?

Does the media favor CGC or OGI?

Do institutionals and insiders hold more shares of CGC or OGI?

Do analysts rate CGC or OGI?

Summary

How does Organigram Global compare to Cronos Group?

Which has more volatility & risk, OGI or CRON?

Is OGI or CRON more profitable?

Does the media refer more to OGI or CRON?

Do institutionals & insiders believe in OGI or CRON?

Which has better earnings & valuation, OGI or CRON?

Do analysts rate OGI or CRON?

Summary

How does Organigram Global compare to SNDL?

Which has higher earnings & valuation, SNDL or OGI?

Does the media refer more to SNDL or OGI?

Is SNDL or OGI more profitable?

Do institutionals & insiders have more ownership in SNDL or OGI?

Which has more risk and volatility, SNDL or OGI?

Do analysts prefer SNDL or OGI?

Summary

How does Organigram Global compare to Tilray Brands?

Does the media favor TLRY or OGI?

Do insiders and institutionals hold more shares of TLRY or OGI?

Do analysts rate TLRY or OGI?

Is TLRY or OGI more profitable?

Which has more risk and volatility, TLRY or OGI?

Which has better valuation & earnings, TLRY or OGI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OGI vs. The Competition

Organigram Global Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools